Deals

We support clients from ideation and planning, through all aspects of diligence, and finally through integration and separation.

 

The Precision Medicine deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicine team provides clients with end-to-end deal support, from deal strategy, target identification and prioritization, commercial, financial and operational diligence, to execution for acquisitions, mergers, and divestitures and post-deal value capture. Our practice has been on the buy- and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.


Team & Contacts

Kristin C. Pothier

Kristin C. Pothier

Global & National, HCLS Deal Advisory & Strategy Leader, KPMG US

+1 617 549 2779
Alasdair Milton, PhD

Alasdair Milton, PhD

Managing Director, Healthcare and Life Sciences Strategy, KPMG US

+1 617-988-5419
Varun Renjen, MD

Varun Renjen, MD

Managing Director, Life Sciences Deal Advisory and Strategy, KPMG US

+1 973-467-9650
Puja Ghelani

Puja Ghelani

Director, Healthcare and Life Sciences Strategy, KPMG US

+1 918-845-2389